Am. J. Respir. Crit. Care Med., Vol 150, No. 1, Jul 1994, 17-22.
Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
CJ Trigg, ND Manolitsas, J Wang, MA Calderon, A McAulay, SE Jordan, MJ Herdman, N Jhalli, JM Duddle and SA Hamilton
Department of Respiratory Medicine and Allergy, St. Bartholomew's Hospital, London, United Kingdom.
The effect of prolonged inhaled corticosteroid treatment on bronchial
immunopathology was assessed in 25 nonsmoking mildly asthmatic subjects
previously receiving intermittent inhaled beta 2-agonist alone. Inhaled
beclomethasone dipropionate (BDP), 500 micrograms twice per day or placebo
was administered for 4 mo in a double-blind parallel group study. Histamine
bronchial provocation, fiberoptic bronchoscopic biopsy, and bronchoalveolar
lavage (BAL) were performed before and after treatment. There was no
difference in bronchial responsiveness or lung function between groups. In
patients treated with BDP compared with placebo, there was a significant
reduction in toluidine blue- staining mast cells (p = 0.028) and total (p =
0.005) and activated eosinophils (p = 0.05) in biopsies but no difference
in eosinophils or eosinophil cationic protein in BAL.
Granulocyte-macrophage colony- stimulating factor expression was
significantly reduced in the bronchial epithelium, and the thickness of
Type III collagen deposition in the bronchial lamina reticularis reduced
from 29.7 +/- 4.4 to 19.8 +/- 3.4 microns (mean +/- 95% confidence
interval) (p = 0.04). No change in helper or activated helper T cells
occurred. Prolonged BDP treatment reduces inflammatory infiltration,
proinflammatory cytokine expression, and subepithelial collagen deposition,
a recognized abnormality in asthma.
This article has been cited by other articles:

|
 |

|
 |
 
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Eur. Respir. J.,
December 1, 2007;
30(6):
1043 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Goldsmith, M. B. Hershenson, M. P. Wolbert, and J. K. Bentley
Regulation of airway smooth muscle {alpha}-actin expression by glucocorticoids
Am J Physiol Lung Cell Mol Physiol,
January 1, 2007;
292(1):
L99 - L106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Chest,
September 1, 2006;
130(3):
741 - 753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fouty, T. Moss, V. Solodushko, and M. Kraft
Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma
Eur. Respir. J.,
June 1, 2006;
27(6):
1160 - 1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bergeron and L.-P. Boulet
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.
Chest,
April 1, 2006;
129(4):
1068 - 1087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Lange, H Scharling, C S Ulrik, and J Vestbo
Inhaled corticosteroids and decline of lung function in community residents with asthma
Thorax,
February 1, 2006;
61(2):
100 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miller, J. Y. Cho, K. McElwain, S. McElwain, J. Y. Shim, M. Manni, J. S. Baek, and D. H. Broide
Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice
Am J Physiol Lung Cell Mol Physiol,
January 1, 2006;
290(1):
L162 - L169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Homer and J. A. Elias
Airway Remodeling in Asthma: Therapeutic Implications of Mechanisms
Physiology,
February 1, 2005;
20(1):
28 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola
Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2004;
1(3):
184 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kim, L. McKinley, J. Siddiqui, G. L. Bolgos, and D. G. Remick
Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust
Am J Physiol Lung Cell Mol Physiol,
September 1, 2004;
287(3):
L503 - L509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Colice
Categorizing Asthma Severity: An Overview of National Guidelines
Clin. Med. Res.,
August 1, 2004;
2(3):
155 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tamaoki, E. Tagaya, K. Kawatani, J. Nakata, Y. Endo, and A. Nagai
Airway Mucosal Thickening and Bronchial Hyperresponsiveness Induced by Inhaled {beta}2-Agonist in Mice
Chest,
July 1, 2004;
126(1):
205 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Quraishi, M. J. Davies, and T. J. Craig
Inflammatory Responses in Allergic Rhinitis: Traditional Approaches and Novel Treatment Strategies
J Am Osteopath Assoc,
May 1, 2004;
104(5_suppl):
7S - 15S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Riccioni, C. Di Ilio, and N. D'Orazio
Pharmacological Treatment of Airway Remodeling: Inhaled Corticosteroids or Antileukotrienes?
Ann. Clin. Lab. Sci.,
April 1, 2004;
34(2):
138 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Grootendorst and K. F. Rabe
Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2004;
1(2):
77 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Castro, S. R. Bloch, M. V. Jenkerson, S. DeMartino, D. L. Hamilos, R. B. Cochran, X. E. L. Zhang, H. Wang, J. P. Bradley, K. B. Schechtman, et al.
Asthma Exacerbations after Glucocorticoid Withdrawal Reflects T Cell Recruitment to the Airway
Am. J. Respir. Crit. Care Med.,
April 1, 2004;
169(7):
842 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pelaia, G. Cuda, A. Vatrella, D. Fratto, R. D. Grembiale, P. Tagliaferri, R. Maselli, F. S. Costanzo, and S. A. Marsico
Effects of Transforming Growth Factor-{beta} and Budesonide on Mitogen-Activated Protein Kinase Activation and Apoptosis in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
July 1, 2003;
29(1):
12 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Sont, W. I. de Boer, W. A. A. M. van Schadewijk, K. Grunberg, J. H. J. M. van Krieken, P. S. Hiemstra, and P. J. Sterk
Fully Automated Assessment of Inflammatory Cell Counts and Cytokine Expression in Bronchial Tissue
Am. J. Respir. Crit. Care Med.,
June 1, 2003;
167(11):
1496 - 1503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chetta, A. Zanini, A. Foresi, M. Del Donno, A. Castagnaro, R. D'Ippolito, S. Baraldo, R. Testi, M. Saetta, and D. Olivieri
Vascular Component of Airway Remodeling in Asthma Is Reduced by High Dose of Fluticasone
Am. J. Respir. Crit. Care Med.,
March 1, 2003;
167(5):
751 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P A Beckett and P H Howarth
Pharmacotherapy and airway remodelling in asthma?
Thorax,
February 1, 2003;
58(2):
163 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Huszar, G. Vass, E. Vizi, Zs. Csoma, E. Barat, Gy. Molnar Vilagos, I. Herjavecz, and I. Horvath
Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma
Eur. Respir. J.,
December 1, 2002;
20(6):
1393 - 1398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Mattos, S. Lim, R. Russell, A. Jatakanon, K. F. Chung, and P. J. Barnes
Matrix Metalloproteinase-9 Expression in Asthma: Effect of Asthma Severity, Allergen Challenge, and Inhaled Corticosteroids
Chest,
November 1, 2002;
122(5):
1543 - 1552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shiba, K. Kasahara, H. Nakajima, and M. Adachi
Structural Changes of the Airway Wall Impair Respiratory Function, Even in Mild Asthma
Chest,
November 1, 2002;
122(5):
1622 - 1626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.J. Vanacker, E. Palmans, R.A. Pauwels, and J.C. Kips
Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats
Eur. Respir. J.,
October 1, 2002;
20(4):
873 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N G Carroll, S Mutavdzic, and A L James
Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma
Thorax,
August 1, 2002;
57(8):
677 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.G. Carroll, S. Mutavdzic, and A.L. James
Distribution and degranulation of airway mast cells in normal and asthmatic subjects
Eur. Respir. J.,
May 1, 2002;
19(5):
879 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Ward, M Pais, R Bish, D Reid, B Feltis, D Johns, and E H Walters
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma
Thorax,
April 1, 2002;
57(4):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. GRUNBERG, R. F. SHARON, J. K. SONT, J. C. C. M. IN'T VEEN, W. A. A. M. VAN SCHADEWIJK, E. P. A. DE KLERK, C. R. DICK, J. H. J. M. VAN KRIEKEN, and P. J. STERK
Rhinovirus-induced Airway Inflammation in Asthma . Effect of Treatment with Inhaled Corticosteroids before and during Experimental Infection
Am. J. Respir. Crit. Care Med.,
November 15, 2001;
164(10):
1816 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. WARD, D. P. JOHNS, R. BISH, M. PAIS, D. W. REID, C. INGRAM, B. FELTIS, and E. HAYDN WALTERS
Reduced Airway Distensibility, Fixed Airflow Limitation, and Airway Wall Remodeling in Asthma
Am. J. Respir. Crit. Care Med.,
November 1, 2001;
164(9):
1718 - 1721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. BENAYOUN, S. LETUVE, A. DRUILHE, J. BOCZKOWSKI, M.-C. DOMBRET, P. MECHIGHEL, J. MEGRET, G. LESECHE, M. AUBIER, and M. PRETOLANI
Regulation of Peroxisome Proliferator-activated Receptor gamma Expression in Human Asthmatic Airways . Relationship with Proliferation, Apoptosis, and Airway Remodeling
Am. J. Respir. Crit. Care Med.,
October 15, 2001;
164(8):
1487 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. ORSIDA, C. WARD, X. LI, R. BISH, J. W. WILSON, F. THIEN, and E. H. WALTERS
Effect of a Long-acting {beta}2-Agonist over Three Months on Airway Wall Vascular Remodeling in Asthma
Am. J. Respir. Crit. Care Med.,
July 1, 2001;
164(1):
117 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. VANACKER, E. PALMANS, J. C. KIPS, and R. A. PAUWELS
Fluticasone Inhibits But Does Not Reverse Allergen-Induced Structural Airway Changes
Am. J. Respir. Crit. Care Med.,
March 1, 2001;
163(3):
674 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Trifilieff, A. El-Hashim, and C. Bertrand
Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment
Am J Physiol Lung Cell Mol Physiol,
December 1, 2000;
279(6):
L1120 - L1128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Kolbe, W Fergusson, M Vamos, and J Garrett
Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack
Thorax,
December 1, 2000;
55(12):
1007 - 1015.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L.-P. BOULET, H. TURCOTTE, M. LAVIOLETTE, F. NAUD, M.-C. BERNIER, S. MARTEL, and J. CHAKIR
Airway Hyperresponsiveness, Inflammation, and Subepithelial Collagen Deposition in Recently Diagnosed versus Long-standing Mild Asthma . Influence of Inhaled Corticosteroids
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1308 - 1313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. BECKY KELLY, W. W. BUSSE, and N. N. JARJOUR
Inhaled Budesonide Decreases Airway Inflammatory Response to Allergen
Am. J. Respir. Crit. Care Med.,
September 1, 2000;
162(3):
883 - 890.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. I. Blyth, T. F. Wharton, M. S. Pedrick, T. J. Savage, and S. Sanjar
Airway Subepithelial Fibrosis in a Murine Model of Atopic Asthma . Suppression by Dexamethasone or Anti-Interleukin-5 Antibody
Am. J. Respir. Cell Mol. Biol.,
August 1, 2000;
23(2):
241 - 246.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med.,
May 1, 2000;
161(5):
1720 - 1745.
[Full Text]
|
 |
|

|
 |

|
 |
 
R. LOUIS, L. C. K. LAU, A. O. BRON, A. C. ROLDAAN, and M. RADERMECKER
The Relationship between Airways Inflammation and Asthma Severity
Am. J. Respir. Crit. Care Med.,
January 1, 2000;
161(1):
9 - 16.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. L. FAUL, E. A. DEMERS, C. M. BURKE, and L. W. POULTER
The Reproducibility of Repeat Measures of Airway Inflammation in Stable Atopic Asthma
Am. J. Respir. Crit. Care Med.,
November 1, 1999;
160(5):
1457 - 1461.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. R. MILLS, R. J. DAVIES, and J. L. DEVALIA
Airway Epithelial Cells, Cytokines, and Pollutants
Am. J. Respir. Crit. Care Med.,
November 1, 1999;
160(5):
S38 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. TAYLOR, M. W. JENSEN, V. KANABAR, R. ENGELSTÄTTER, V. W. STEINIJANS, P. J. BARNES, and B. J. O'CONNOR
A Dose-dependent Effect of the Novel Inhaled Corticosteroid Ciclesonide on Airway Responsiveness to Adenosine-5'-Monophosphate in Asthmatic Patients
Am. J. Respir. Crit. Care Med.,
July 1, 1999;
160(1):
237 - 243.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Mautino, C. Henriquet, D. Jaffuel, J. Bousquet, and F. Capony
Tissue Inhibitor of Metalloproteinase-1 Levels in Bronchoalveolar Lavage Fluid from Asthmatic Subjects
Am. J. Respir. Crit. Care Med.,
July 1, 1999;
160(1):
324 - 330.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. L J van Rensen, K. C M Straathof, M. A Veselic-Charvat, A. H Zwinderman, E. H Bel, and P. J Sterk
Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
Thorax,
May 1, 1999;
54(5):
403 - 408.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. K. SONT, L. N. A. WILLEMS, E. H. BEL, J.H. J. M. van KRIEKEN, J. P. VANDENBROUCKE, P. J. STERK, and the AMPUL Study Group
Clinical Control and Histopathologic Outcome of Asthma when Using Airway Hyperresponsiveness as an Additional Guide to Long-Term Treatment
Am. J. Respir. Crit. Care Med.,
April 1, 1999;
159(4):
1043 - 1051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E Orsida, X. Li, B. Hickey, F. Thien, J. W Wilson, and E H. Walters
Vascularity in asthmatic airways: relation to inhaled steroid dose
Thorax,
April 1, 1999;
54(4):
289 - 295.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Pineiro, L. X. Wei, B. C. Seidenberg, T. F. Reiss, and for the Montelukast/Beclomethasone Study Group*
Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma: A Randomized, Controlled Trial
Ann Intern Med,
March 16, 1999;
130(6):
487 - 495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. LIM, A. JATAKANON, M. JOHN, T. GILBEY, B. J. O'CONNOR, K. F. CHUNG, and P. J. BARNES
Effect of Inhaled Budesonide on Lung Function and Airway Inflammation . Assessment by Various Inflammatory Markers in Mild Asthma
Am. J. Respir. Crit. Care Med.,
January 1, 1999;
159(1):
22 - 30.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. W. CHU, J. L. HALLIDAY, R. J. MARTIN, D. Y. M. LEUNG, S. J. SZEFLER, and S. E. WENZEL
Collagen Deposition in Large Airways May Not Differentiate Severe Asthma from Milder Forms of the Disease
Am. J. Respir. Crit. Care Med.,
December 1, 1998;
158(6):
1936 - 1944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L Faul, C. T Leonard, C. M Burke, V. J Tormey, and L. W Poulter
Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time
Thorax,
September 1, 1998;
53(9):
753 - 761.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. S. Warshamana, S. Martinez, J. A. Lasky, M. Corti, and A. R. Brody
Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation
Am J Physiol Lung Cell Mol Physiol,
April 1, 1998;
274(4):
L499 - L507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE
Efficacy and Safety of Inhaled Corticosteroids . New Developments
Am. J. Respir. Crit. Care Med.,
March 1, 1998;
157(3):
S1 - 53.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C Siersted, J. Boldsen, H. S Hansen, G. Mostgaard, N. Hyldebrandt, P J. Rees, S. J W Evans, and H. C Siersted
Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study • Commentary: Risk factors for underdiagnosis of asthma in adolescence • Commentary: Identifying the correct risks in diagnosis • Commentary: Improving the diagnostic rate in asthma: a community issue
BMJ,
February 28, 1998;
316(7132):
651 - 657.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. LAITINEN, A. ALTRAJA, M. KAMPE, M. LINDEN, I. VIRTANEN, and L. A. LAITINEN
Tenascin Is Increased in Airway Basement Membrane of Asthmatics and Decreased by an Inhaled Steroid
Am. J. Respir. Crit. Care Med.,
September 1, 1997;
156(3):
951 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. GRÜNBERG, H. H. SMITS, M. C. TIMMERS, E. P. A. de KLERK, R. J. E. M. DOLHAIN, E. C. DICK, P. S. HIEMSTRA, and P. J. STERK
Experimental Rhinovirus 16 Infection . Effects on Cell Differentials and Soluble Markers in Sputum in Asthmatic Subjects
Am. J. Respir. Crit. Care Med.,
July 1, 1997;
156(2):
609 - 616.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. R. ROCHE
Inflammatory and Structural Changes in the Small Airways in Bronchial Asthma
Am. J. Respir. Crit. Care Med.,
May 1, 1997;
157(5):
191 - 194.
[Full Text]
|
 |
|

|
 |

|
 |
 
L. M. FABBRI, G. CARAMORI, B. BEGHÉ, A. PAPI, and A. CIACCIA
Physiologic Consequences of Long-term Inflammation
Am. J. Respir. Crit. Care Med.,
May 1, 1997;
157(5):
195 - 198.
[Full Text]
|
 |
|
Copyright © 1994 American Thoracic Society
|
|
|